Search citation statements

Order By: Relevance
Select...
3
1
0
6
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

0
6
0
Order By: Relevance
“…Rizzo et al reported that HLA‐G −14 bp/−14 bp genotype could regulate the methotrexate‐treated response in RA patients with higher levels of HLA‐G and a consequent positive therapeutic result. In that study, a significantly higher frequency of the −14 bp/−14 bp genotype was observed in ‘responder’ patients compared with ‘nonresponders’ for clinical response to the methotrexate treatment (18, 34). Our recent study indicated that −14 bp/−14 bp polymorphism in the HLA‐G gene could be a risk factor for the pathogenesis of the idiopathic dilated cardiomyopathy (19).…”
Section: Discussionmentioning
Create an account to read the remaining citation statements from this report. You will also get access to:
  • Search over 1.2b+ citation statments to see what is being said about any topic in the research literature
  • Advanced Search to find publications that support or contrast your research
  • Citation reports and visualizations to easily see what publications are saying about each other
  • Browser extension to see Smart Citations wherever you read research
  • Dashboards to evaluate and keep track of groups of publications
  • Alerts to stay on top of citations as they happen
  • Automated reference checks to make sure you are citing reliable research in your manuscripts
  • 7 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 130,000 students researchers, and industry experts at use scite

See what students are saying

rupbmjkragerfmgwileyiopcupepmcmbcthiemesagefrontiersapsiucrarxivemeralduhksmucshluniversity-of-gavle
“…Rizzo et al reported that HLA‐G −14 bp/−14 bp genotype could regulate the methotrexate‐treated response in RA patients with higher levels of HLA‐G and a consequent positive therapeutic result. In that study, a significantly higher frequency of the −14 bp/−14 bp genotype was observed in ‘responder’ patients compared with ‘nonresponders’ for clinical response to the methotrexate treatment (18, 34). Our recent study indicated that −14 bp/−14 bp polymorphism in the HLA‐G gene could be a risk factor for the pathogenesis of the idiopathic dilated cardiomyopathy (19).…”
Section: Discussionmentioning
“…Of note, a 14-bp insertion/deletion polymorphism in the 3=-untranslated region of exon 8 of the HLA-G gene was reported to be associated with the stability and splicing pattern of HLA-G mRNA isoforms, consequently affects HLA-G protein expression patterns and has possible implications for clinical significance [14,15]. In line with this, Rizzo et al reported that HLA-G the 14-bp deletion homozygous genotype could regulate the methotrexate-treated response in rheumatoid arthritis patients with higher levels of HLA-G and a consequent positive therapeutic result [23]. However, this observation was challenged by the findings in another study that the HLA-G 14 bp polymorphism was not associated with the response to long-term therapy with methotrexate response in rheumatoid arthritis [24].…”
Section: Discussionmentioning
“…However, Kim et al lacked to find an association between HLA‐G −1202T>C and −586C>T polymorphisms and susceptibility to develop RA, while Veit et al associated the HLA‐G 14 bp del/ins polymorphism with juvenile idiopathic arthritis, but not with RA. Also the role of HLA‐G 14 bp del/ins polymorphism in relation to the treatment with methotrexate in RA patients seems controversial . Nevertheless it should be considered that most genetic association studies suffer from being based on small numbers of patients and controls.…”
Section: Clinical and Laboratorial Characteristic Of Rheumatoid Arthrmentioning